Esophageal Cancer Market Size, Share, Analysis, Region & Country Forecast Till 2027

 

Esophageal Cancer

Cancer is one of the leading causes of death worldwide and is expected to witness the expansion of patient population in the years to come. One of the types of cancer that affect the food pipe connecting the mouth and stomach is the esophageal cancer which is majorly prevalent among the older adults belonging to 55 years and above age group. Market Research Future (MRFR) has found out that the global esophageal cancer market is projected to grow at a compound annual rate of 8.7% during the forecast period 2017 to 2023. It is underlined in the report that the market is anticipated to scale a decent valuation of USD 1000.1 Mn towards the close of 2023.

The rising burden of cancer has paved the way for innovation in the market. It is one of the prime areas of research in the medical field. With the increasing number of drug patent applications in conjunction with the rising count of clinical trials, the esophageal cancer market is expected to witness a boom over the next couple of years. Key players are anticipated to exponentially invest in the development of more effective treatments which is forecasted to aid the proliferation of the esophageal market in the foreseeable future.

Addiction to tobacco, betel nuts, etc. is the key factor responsible for triggering esophageal cancer. Increasing shift towards a sedentary lifestyle has led to an increase in addiction problems among the masses. This, in turn, is expected to catalyze the growth of patient population. The future trajectory of the esophageal market is likely to remain highly lucrative over the next couple of years.

People are getting increasingly aware of the availability of treatments which is poised to aid market expansion. The support extended by governments in conjunction with the early detection of the disease has unleashed massive opportunities for the market players. It is anticipated to augment the esophageal cancer market in the long run.

Request Free Sample Copy at:https://www.marketresearchfuture.com/sample_request/3280

Market Segmentation

By type, the global esophageal cancer market has been segmented into esophageal squamous-cell carcinoma, esophageal adenocarcinoma, and others.

On the basis of phase, the esophageal cancer market has been segmented into phase I, phases II, and phases III.

The esophageal cancer market by treatment, has been segmented into surgery, chemotherapy and radiotherapy and other.

Competitive Dashboard

The share analysis of the esophageal market offered in this MRFR report studies key players such as Amgen Inc. (U.S.), F. Hoffmann-La Roche (Switzerland), Eli Lilly and Company (U.S.), Bristol-Myers Squibb Company (U.S.), Bristol-Myers Squibb (U.S.), Boehringer Ingelheim GmbH (Germany), GlaxoSmithKline Plc. (U.K), Johnson & Johnson (U.S.), Novartis AG (Switzerland), Gilead Sciences, Inc. (U.S.), and Merck & Co., Inc. (U.S.).

Regional Analysis

The comprehensive geographical study of the global esophageal market spans across North America, Europe, Asia Pacific, and the Middle East & Africa (MEA). North America is highly affected by the addiction of tobacco and other drugs which is expected to support the growth of the patient population. It is anticipated to catalyze the growth of the esophageal cancer market in the region. In addition, the support provided by the government for research & development of effective drugs is expected to propel market expansion over the next couple of years.

Europe is anticipated to maintain its prominence at the second spot through the assessment period. The region is poised to exhibit a rise in research & development. It is likely to favor growth of the regional esophageal market. In addition, Asia Pacific signifies developmental opportunities owing to the presence of a huge patient population.

Industry News

  • In January 2019, Nivolumab, a medicine used for treating cancer, has extended OS in esophageal cancer of advanced stage as an outcome of the phase 3 of a clinical trial.

Browse Detailed TOC with COVID-19 Impact Analysis at:https://www.marketresearchfuture.com/reports/esophageal-cancer-market-3280

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com


Location: New York, NY, USA

Comments

Post a Comment

Popular posts from this blog

ICP-OES Spectrometer Industry Size, Share, Key Players, Growth Trend, and Forecast Till 2030

Image
  The global  ICP-OES Spectrometer Industry  was valued at USD 521.4 million in 2018 at a CAGR of 7.2% during the forecast period of 2019 to 2025. ICP-OES Spectrometer is an analytical instrument that is used for the detection of chemical elements. It uses the technique of inductively coupled plasma optical emission spectroscopy (ICP-OES) for carrying out its analysis procedure. Certain factors that propel the growth of the ICP-OES Spectrometer Industry include increasing R&D expenditure for the development of better analytical systems and growing technological advancements. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8120 However, the high cost of instruments and requirement of large capital investment for setting up instrument manufacturing plants is hindering the growth of the global ICP-OES Spectrometer Industry in the forecast period. Currently, the global ICP-OES Spectrometer Industry is dominated by several players. ...
Read more

Opioid Withdrawal Treatment Market Growth, Size Analysis, DROT, PEST, Porter’s, Region & Country Forecast Till 2030

Image
The global  opioid withdrawal treatment growth market held a market value of USD 1.8 billion in 2018 and is projected to grow at a CAGR of 10.1% over the forecast period. Opioids are drugs such as heroin, opium, morphine, codeine, and methadone that are used in cases of severe, postsurgical, or chronic pain. In some cases, usage of opioids causes addiction, and Opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment, which is known as opioids withdrawal treatment. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8123 Segmentation The global opioid withdrawal treatment market has been segmented into drug type and distribution channel. By drug type, the market has been segmented into the nonsteroidal anti-inflammatory drugs, anti-nausea medications, a...
Read more

Preclinical Imaging Market Trends, Size, Key Factors, Major Players, Growth Strategies, Forecast Till 2027

Image
Preclinical Imaging Market Trends , Revenue Forecast, Competitive Landscape, Growth Factors, and Research Report: by Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), by Reagent (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) The global preclinical imaging anticipated to have held a market value of USD 2.01 billion in the year 2017 and is expected to grow at a CAGR of 6.3% during the forecast period. Preclinical imaging solutions are used during the preclinical research for visualization of living animals. It is playing important role during drug development process. It is evaluating the effectiveness and safety of new treatments and describing drug distribution patterns before clinical use. preclinical imaging solutions has broad application field such as, neurology; cardiology; inflammation; infectious diseases; cancer research; functional and anatomical neuroimaging, orthopedics; and cardiac imaging. Requ...
Read more